Synthesis 2015; 47(02): 228-234
DOI: 10.1055/s-0034-1378910
paper
© Georg Thieme Verlag Stuttgart · New York

5′-Noraristeromycin C-Nucleosides Based on Imidazo[1,2-a]pyrazine

Wei Ye
Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, USA   Fax: +1(334)8440239   eMail: schnest@auburn.edu
,
Stewart W. Schneller*
Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, USA   Fax: +1(334)8440239   eMail: schnest@auburn.edu
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 10. Juni 2014

Accepted after revision: 03. Oktober 2014

Publikationsdatum:
12. November 2014 (online)


Preview

Abstract

The preparation of two C-5′-nor-3-deazaaristeromycin dia­stereomeric analogues possessing a bridgehead nitrogen is described from (3aR,4R,6S,6aS)-2,2-dimethyl-6-vinyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol that served as the cyclopentyl unit of the target carbocyclic nucleosides and as the scaffold upon which the compounds were built. The process evolved via a de novo approach for constructing the requisite fused imidazo unit between the aforementioned cyclopentyl ring and a readily available 2,3-dichloropyrazine. The syntheses were accomplished in 11 and 8 steps depending on the diastereomer sought.